<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-13T01:15:50Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2445/181261" metadataPrefix="qdc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2445/181261</identifier><datestamp>2025-12-04T21:13:59Z</datestamp><setSpec>com_2072_1057</setSpec><setSpec>col_2072_478781</setSpec><setSpec>col_2072_478916</setSpec><setSpec>col_2072_478917</setSpec><setSpec>col_2072_478929</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>β-Adrenergic receptors activate exchange protein directly activated by cAMP (Epac), translocate Munc13-1, and enhance the Rab3A-RIM1α interaction to potentiate glutamate release at cerebrocortical nerve terminal</dc:title>
   <dc:creator>Ferrero, Jose J.</dc:creator>
   <dc:creator>Alvarez, Ana M.</dc:creator>
   <dc:creator>Ramírez-Franco, Jorge</dc:creator>
   <dc:creator>Godino, María C.</dc:creator>
   <dc:creator>Bartolomé-Martín, David</dc:creator>
   <dc:creator>Aguado, Carolina</dc:creator>
   <dc:creator>Torres, Magdalena</dc:creator>
   <dc:creator>Luján, Rafael</dc:creator>
   <dc:creator>Ciruela Alférez, Francisco</dc:creator>
   <dc:creator>Sánchez-Prieto, José</dc:creator>
   <dc:subject>Receptors adrenèrgics</dc:subject>
   <dc:subject>Nervis</dc:subject>
   <dc:subject>Proteïnes</dc:subject>
   <dc:subject>Adrenaline receptors</dc:subject>
   <dc:subject>Nerves</dc:subject>
   <dc:subject>Proteins</dc:subject>
   <dcterms:abstract>The adenylyl cyclase activator forskolin presynaptically facilitates synaptic transmission through cAMP-dependent protein kinase, PKA. However, cAMP also increases glutamate release via PKA-independent mechanisms, although the downstream presynaptic targets remain largely unknown. Here we found that a PKA-independent release component can be isolated in cerebrocortical nerve terminals after blocking Na+ channels with tetrodotoxin. 8-pCPT-2-O-Me-cAMP, 8pCPT, a specific activator of the exchange protein directly activated by cAMP, Epac, mimicks and occluded forskolin-induced release. The Epac mediated increase in release is dependent on phospholipase C, and increased phosphatidylinositol (4,5)-bisphosphate hydrolysis. Furthermore, the potentiation of release does not depend on protein kinase C, although it is reduced by the diacylglycerol-binding site antagonist calphostin C. Epac activation translocates the active zone protein Munc13-1 from soluble to particulate fractions, increases the association between Rab3A and Rim1αand redistributes synaptic vesicles to positions closer to the presynaptic membrane. We also found that the β-adrenergic receptor agonist, isoproterenol, mimicked all these responses consistent with high-resolution immunoelectron microscopy and immunocytochemical data showing presynaptic expression of the β-ARs at a subset of glutamatergic synapses of the cerebral cortex. It is concluded that β adrenergic receptors couple to a cAMP/Epac/PLC/Munc13/Rab3/Rim dependent pathway to enhance glutamate release at cerebrocortical nerve terminals.</dcterms:abstract>
   <dcterms:issued>2021-11-16T16:43:05Z</dcterms:issued>
   <dcterms:issued>2021-11-16T16:43:05Z</dcterms:issued>
   <dcterms:issued>2013-10-25</dcterms:issued>
   <dcterms:issued>2021-11-16T16:43:06Z</dcterms:issued>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:relation>Reproducció del document publicat a: https://doi.org/10.1074/jbc.M113.463877</dc:relation>
   <dc:relation>Journal of Biological Chemistry, 2013, vol. 288, num. 43, p. 31370-31385</dc:relation>
   <dc:relation>https://doi.org/10.1074/jbc.M113.463877</dc:relation>
   <dc:rights>(c) American Society for Biochemistry and Molecular Biology, 2013</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:publisher>American Society for Biochemistry and Molecular Biology</dc:publisher>
   <dc:source>Articles publicats en revistes (Patologia i Terapèutica Experimental)</dc:source>
</qdc:qualifieddc></metadata></record></GetRecord></OAI-PMH>